Literature DB >> 1287903

The cost-effectiveness of chemoprophylaxis with Maloprim administered by primary health care workers in preventing death from malaria amongst rural Gambian children aged less than five years old.

J Picard1, A Mills, B Greenwood.   

Abstract

In recent trials in The Gambia, mass chemoprophylaxis with Maloprim administered over several years by primary health care workers to children aged 3-59 months has reduced both mortality and morbidity without inducing impairment of natural immunity or significant development of drug resistance. Taking expenditure of both time and money, by both public authorities and village volunteers, into account, the costs and the cost effectiveness of such mass chemoprophylaxis are estimated here. The cost per child protected per season was (1990 US) $2.84; the cost per childhood death averted was $143. Both costs compare favourably with those of permethrin bed net impregnation. So in some circumstances where malaria is holoendemic, control of childhood malaria by chemoprophylaxis may be more economically efficient than provision of impregnated bed nets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287903     DOI: 10.1016/0035-9203(92)90135-y

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Strengthening health research capacity in developing countries: a critical element for achieving health equity.

Authors:  C Sitthi-Amorn; R Somrongthong
Journal:  BMJ       Date:  2000-09-30

2.  Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.

Authors:  Lesong Conteh; Edith Patouillard; Margaret Kweku; Rosa Legood; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

3.  Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania.

Authors:  Deus S Ishengoma; Bruno P Mmbando; Method D Segeja; Michael Alifrangis; Martha M Lemnge; Ib C Bygbjerg
Journal:  Malar J       Date:  2013-09-22       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.